Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKosmos Energy Regulatory News (KOS)

Share Price Information for Kosmos Energy (KOS)

Share Price is delayed by 15 minutes
Get Live Data
217.00    0.00 (0.00%)
Bid:
208.00
Ask:
226.00
Spread: 18.00 (8.654%)
Market Cap: £1.29b
KOS Live PriceLast checked at - London Stock Exchange

Intraday Kosmos Energy Share Chart

Director/PDMR Shareholding

9 Jun 2025 07:00

RNS Number : 8770L
Kosmos Energy Limited
09 June 2025
 

Kosmos Energy Ltd (the "Company")PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

9 June 2025

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Shares in the Company:

PDMR

Date of transaction

No. of shares vested

No. of shares granted

No. of shares sold or withheld

Roy A. Franklin

4 June 2025

0

0

299

Roy A. Franklin

5 June 2025

0

96,591

0

Deanna L. Goodwin

5 June 2025

0

96,591

0

Sir John Douglas Kelso Grant

4 June 2025

0

0

275

Sir John Douglas Kelso Grant

5 June 2025

0

0

27,923

Sir John Douglas Kelso Grant

5 June 2025

0

96,591

0

Maria Moraeus Hanssen

5 June 2025

0

96,591

0

Adebayo O. Ogunlesi

5 June 2025

0

96,591

0

Steven M. Sterin

5 June 2025

0

96,591

0

J. Michael Stice

5 June 2025

0

96,591

0

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

Josh R. Marion

Senior Vice President, General Counsel and Corporate Secretary

CONTACT:

Investor Relations

Jamie Buckland +44 203 954 2831 jbuckland@kosmosenergy.com

Media Relations

Thomas Golembeski +1-214-445-9674 tgolembeski@kosmosenergy.com

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Roy A. Franklin

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

299 shares withheld by the Issuer to satisfy the tax withholding requirement arising from the vesting of restricted share units granted to the reporting person under the Issuer's Long Term Incentive Plan (the "Plan").

Shares granted or vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

1.81

Volume

299

Total

541.19

 

 

e)

Aggregated information 

Price

1.81

Volume

299

Total

541.19

f)

Date of the transactions

4 June 2025

g)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

1.76

Volume

96,591

Total

170,000.16

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

 

 

e)

Aggregated information 

Price

1.76

Volume

96,591

Total

170,000.16

f)

Date of the transactions

5 June 2025

g)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Deanna L. Goodwin

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

1.76

Volume

96,591

Total

170,000.16

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

 

 

e)

Aggregated information 

Price

1.76

Volume

96,591

Total

170,000.16

f)

Date of the transactions

5 June 2025

g)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Sir John Douglas Kelso Grant

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

275 shares withheld by the Issuer to satisfy the tax withholding requirement arising from the vesting of restricted share units granted to the reporting person under the Issuer's Long Term Incentive Plan (the "Plan").

Shares granted or vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

1.81

Volume

275

Total

497.75

 

 

e)

Aggregated information 

Price

1.81

Volume

275

Total

497.75

f)

Date of the transactions

4 June 2025

g)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

27,923 shares sold to partially cover income tax liability from the vesting of restricted share units granted to the reporting person under the Plan.

Shares granted or vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

1.81

Volume

27,923

Total

50,540.63

 

 

e)

Aggregated information 

Price

1.81

Volume

27,923

Total

50,540.63

f)

Date of the transactions

5 June 2025

g)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

1.76

Volume

96,591

Total

170,000.16

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

 

 

e)

Aggregated information 

Price

1.76

Volume

96,591

Total

170,000.16

f)

Date of the transactions

5 June 2025

g)

Place of the transaction

NYSE

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Maria Moraeus Hanssen

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

1.76

Volume

96,591

Total

170,000.16

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

 

 

e)

Aggregated information 

Price

1.76

Volume

96,591

Total

170,000.16

f)

Date of the transactions

5 June 2025

g)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Adebayo O. Ogunlesi

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

1.76

Volume

96,591

Total

170,000.16

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

e)

Aggregated information 

Price

1.76

Volume

96,591

Total

170,000.16

f)

Date of the transactions

5 June 2025

g)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Steven M. Sterin

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

1.76

Volume

96,591

Total

170,000.16

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

e)

Aggregated information 

Price

1.76

Volume

96,591

Total

170,000.16

f)

Date of the transactions

5 June 2025

g)

Place of the transaction

NYSE

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

J. Michael Stice

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

1.76

Volume

96,591

Total

170,000.16

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

e)

Aggregated information 

Price

1.76

Volume

96,591

Total

170,000.16

f)

Date of the transactions

5 June 2025

g)

Place of the transaction

NYSE

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSUFIMEISEEM
Date   Source Headline
6th Feb 20187:00 amRNSReserves Based Lending Facility
5th Feb 20187:00 amRNSDrilling Update
26th Jan 20187:00 amRNSNotice of Results
12th Dec 20177:00 amRNSUPDATE ON DRILLING PROGRAM
6th Nov 20177:00 amRNS3rd Quarter Results
31st Oct 20177:00 amRNSKosmos Provides Update on Exploration Program
24th Oct 20177:00 amRNSKOSMOS ENERGY EXPANDS POSITION IN GULF OF GUINEA
10th Oct 20177:00 amRNSThird Quarter 2017 Results Reporting Schedule
25th Sep 20177:00 amRNSITLOS RULING
23rd Aug 20177:00 amRNSSuccessful Completion of Tortue Drill Stem Test
21st Aug 20177:00 amRNSAdmission to trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.